Eli Lilly’s R&D has yielded innovations such as the metabolic disorder drugs Mounjaro and Zepbound, both discovered in the company’s labs. Lilly is now committing $4.5 billion for in-house innovations ...

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain INDIANAPOLIS, Nov. 3, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE ...

Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched experimental weight-loss pill, orforglipron, ...

On Wednesday, Eli Lilly And Co. (NYSE:LLY) announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. As the company inches ...

Eli Lilly posts 54% revenue growth, raises guidance, and drives innovation in obesity and diabetes care. Read here for an ...

(Reuters) — Indianapolis-based drugmaker Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched ...

In an announcement Monday, Nov. 3, the Indianapolis-based pharmaceutical company said the new site will manufacture its weight-loss pill, orforglipron, and other oral medicines. Lilly expects to ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

INDIANAPOLIS, Nov. 17, 2023 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced plans to construct a new $2.5 billion high-tech manufacturing site in Alzey, Rhineland-Palatinate, Germany. This ...

I n Southeastern Wisconsin, Eli Lilly and Company will invest $3 billion to expand a Kenosha County manufacturing facility it acquired from Nexus Pharmaceuticals Inc. earlier this year. Lilly expects ...